Official Publications Sino Biopharmaceutical Limited

Equities

Delayed Hong Kong S.E. Other stock markets 09:13:00 03/06/2024 am IST			5-day change	1st Jan Change
2.79 ^HKD	-1.76%		-1.41%	-19.31%

24/05	Sino Biopharmaceutical's Renal Cancer Combination Treatment Shows Promise in Phase III Trials	MT
23/05	Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma	CI

Minutes of the general assembly	15/23/15	CO
Acquisition	09/23/09	CO
Mixed general shareholder meeting	28/23/28	CO
Annual ESG Report	27/23/27	CO
Annual Report	31/23/31	CO
Changes in management and corporate officers	14/22/14	CO
Business information	22/22/22	CO
Minutes of the general assembly	06/22/06	CO
Annual ESG Report	27/22/27	CO